SCHEDULE: Vanguard Reports 7.52% Stake in Labcorp Holdings
Schedule 13G Filing
Vanguard Capital Management disclosed a beneficial ownership of 7.52% in Labcorp Holdings Inc. as of March 31, 2026.
Summary
- Vanguard Capital Management, along with its affiliates, now beneficially owns 6,201,512 shares of Labcorp Holdings Inc. common stock.
- This represents 7.52% of the total class of securities.
- Vanguard Capital Management has sole voting power over 825,392 shares and sole dispositive power over 6,201,512 shares.
- The filing is made in accordance with SEC Release No. 34-39538, reflecting securities held by Vanguard funds and managed accounts.
- The securities were acquired and are held in the ordinary course of business and not for the purpose of influencing control of the issuer.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it is a routine disclosure of institutional ownership and does not contain new operational or financial performance information.
Positives
- Vanguard's significant stake indicates confidence in Labcorp's long-term prospects.
- The filing confirms that the securities are held in the ordinary course of business, suggesting a stable, non-activist investment approach.
Future Outlook
This filing does not contain forward-looking statements or guidance. It is a disclosure of current beneficial ownership.
Industry Context
StockSavvy.ai notes that large institutional ownership, as indicated by Vanguard's filing, is common in the healthcare and diagnostics sector, reflecting the sector's stability and growth potential. Labcorp Holdings operates in a competitive landscape with companies like Quest Diagnostics.
Stakeholder Impact
- Shareholders: The filing confirms a major institutional investor's significant stake, which can be viewed as a positive signal of confidence in the company's value and stability.
Next Steps
- Vanguard Capital Management will continue to hold and manage its investment in Labcorp Holdings Inc. in the ordinary course of business.
Key Dates
| Date | Description |
|---|---|
| 01/12/1998 | SEC Release No. 34-39538 referenced for reporting securities beneficially owned by Vanguard entities. |
| 03/31/2026 | Date of Event Which Requires Filing of this Statement. |
| 04/28/2026 | Date of Certification by Ashley Grim, Head of Global Fund Administration for Vanguard Capital Management. |
Keywords
Labcorp Holdings, Vanguard Capital Management, Schedule 13G, Beneficial Ownership, SEC Filing, Investment Management, Healthcare, Diagnostics
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.